Drug industry calls out telehealth company Hims & Hers' Super Bowl ad touting its knock-off weight loss medications.

Donald Trump's second administration has put forth an avalanche of policy changes and political pronouncements that have jolted Washington and the world.

Hims & Hers believes that is where the controversy lies. “We called on the industry and said that they need to change — and ...

Donald Trump's second administration has executed significant policy changes and political announcements, following his ...

A group of Senators has warned the FDA about an ad expected to air during Sunday’s big game that they believe misleads ...

Two U.S. senators wrote a letter to the Food and Drug Administration on Friday expressing concerns about an upcoming Super ...

None of the 49 people detained in a raid on a makeshift nightclub in Adams County are facing criminal charges, according to ...

The stop-work order on U.S.A.I.D.-funded research has left thousands of people with experimental drugs and devices in their ...

The U.S. Food and Drug Administration has approved Axsome Therapeutics' Symbravo (meloxicam and rizatriptan) for the acute ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

and U.S. Food and Drug Administration. Fink added that some exceptions would be made for communications affecting "critical health, safety, environmental, financial, or national security functions." A ...